Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trials to Evaluate the Immunogenicity and Safety of Adsorption-free Diphtheria and Tetanus (Three-component) Combined Vaccine in 2-month-old Infants and Young Children

NCT07112144 is registered in ClinicalTrials.gov with Changchun BCHT Biotechnology Co. as lead sponsor.

NCT NCT07112144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07112144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trials to Evaluate the Immunogenicity and Safety of Adsorption-free Diphtheria and Tetanus (Three-component) Combined Vaccine in 2-month-old Infants and Young Children
Lead sponsor
Changchun BCHT Biotechnology Co.
Phase
Phase 3
Overall status
Recruiting
Start date
June 13, 2025
Completion date
June 30, 2032
Enrollment
1,650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevent diphtheria, prevent tetanus, prevent whooping cough